US National Security, China and Biotechnology in 2024 4/5/2024

Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS 4/5/2024

FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy 4/5/2024

Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters 4/5/2024

Novartis to File for Pluvicto Label Expansion After Promising Phase III Data 4/5/2024

Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US 4/19/2024

FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024

Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024

Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024

Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff 4/19/2024

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC 4/19/2024

Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024

Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024

Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024

Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024

Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024

Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024